News

Before the Journals: PFO Closure in Cryptogenic Stroke


 

The full results of the CLOSURE I trial to reduce the risk of stroke in patients with patent foramen ovale who had a previous cryptogenic stroke are now published in the March 15 issue of the New England Journal of Medicine (N. Engl. J. Med. 2012;366:991-9). The results are not substantially different from our report on the results of the trial when they were presented at the American Heart Association scientific sessions in 2010 (See related story on the sidebar).

The percentages of patients who experienced the primary end points of transient ischemic attack, stroke, or the composite of the two were slightly different in the two reports, but this did not alter the results of the statistical analyses or the conclusions drawn by the investigators.

Recommended Reading

Desensitization Succeeds for Aspirin-Allergic Heart Patients
MDedge Internal Medicine
Tenecteplase Edges TPA in Acute Stroke
MDedge Internal Medicine
Atrial Fibrillation, Stroke Risks Rise in Rheumatoid Arthritis
MDedge Internal Medicine
Duodenal Switch May Excel at Type 2 Diabetes Resolution
MDedge Internal Medicine
Slight Hyperglycemia Risk Shouldn't Deter Statin Use
MDedge Internal Medicine
Role of Patent Foramen Ovale Varies in Cryptogenic Strokes
MDedge Internal Medicine
Asymptomatic Carotid Disease Impairs Cognitive Function
MDedge Internal Medicine
Study Hints at Statins' Protective Effect Against Parkinson's
MDedge Internal Medicine
Initial EVAR Improves Mortality After Second Aortic Repair
MDedge Internal Medicine
Exercise Improves Symptoms in Atrial Fibrillation
MDedge Internal Medicine

Related Articles